CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 61 enrolled
Drug / intervention
Prototype Nasal Dilator +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01122849
NCT01122849Phase 2Completed

Exploratory Subjective Sleep Study of a Prototype Nasal Dilator

GlaxoSmithKline·interventional·Posted May 13, 2010·Updated Apr 9, 2018

In Brief

A Phase 2 clinical trial evaluating Prototype Nasal Dilator, Marketed Nasal Strip, and 1 other intervention for Sleep Disorders and Congestion, Nasal. Completed, enrolled 61 participants across 2 sites.

Detailed Summary

The purpose of this exploratory study is to evaluate the subjective measures of congestion and sleep quality in subjects who suffer from chronic nasal congestion and report trouble with their sleep.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 13, 2010
Enrollment StartOct 1, 2009
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 16.1 years ago

Interventions

Prototype Nasal Dilatordevice

Prototype nasal dilator AB2R11

Marketed Nasal Stripdevice

Breathe Right Nasal Strip- Clear small/medium

Placebo Nasal Stripdevice

Placebo strip